Terms: = Uterine cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Diagnosis
4 results:
1. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer.
Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
[TBL] [Abstract] [Full Text] [Related]
2. pim-1 may function as an oncogene in cervical cancer via activating the EGFR signaling.
Yang H; He K; Dong W; Fang J; Zhong S; Tang L; Long L
Int J Biol Markers; 2020 Sep; 35(3):67-73. PubMed ID: 32914663
[TBL] [Abstract] [Full Text] [Related]
3. Papillary immature metaplasia of the uterine cervix: a report of 5 cases with an emphasis on the differential diagnosis from reactive squamous metaplasia, high-grade squamous intraepithelial lesion and papillary squamous cell carcinoma.
Kang GH; Min K; Shim YH; Kim KR
J Korean Med Sci; 2001 Dec; 16(6):762-8. PubMed ID: 11748359
[TBL] [Abstract] [Full Text] [Related]
4. Papillary immature metaplasia of the cervix: a distinct subset of exophytic cervical condyloma associated with HPV-6/11 nucleic acids.
Ward BE; Saleh AM; Williams JV; Zitz JC; Crum CP
Mod Pathol; 1992 Jul; 5(4):391-5. PubMed ID: 1323109
[TBL] [Abstract] [Full Text] [Related]